Zhitong Finance App News, Kingsley Biotech (01548.HK) announced that Legend Biotech Co., Ltd. (Legend Biotech, a non-wholly-owned subsidiary of the company and listed on the US NASDAQ Global Select Market in the form of American Depositary Shares) has submitted Form 6-K to the US Securities and Exchange Commission (US Securities Regulatory Commission) on October 15, 2024 (New York time, after the Hong Kong trading session on October 15, 2024), and announced that, according to Legend Biotech and Janssen Biotech, Inc. (Janssen) Under the cooperation and licensing agreement concluded on December 21, 2017, CARVYKTI® generated net trade sales of approximately US$286 million for the quarter ended September 30, 2024.

Zhitongcaijing · 10/15 12:17
Zhitong Finance App News, Kingsley Biotech (01548.HK) announced that Legend Biotech Co., Ltd. (Legend Biotech, a non-wholly-owned subsidiary of the company and listed on the US NASDAQ Global Select Market in the form of American Depositary Shares) has submitted Form 6-K to the US Securities and Exchange Commission (US Securities Regulatory Commission) on October 15, 2024 (New York time, after the Hong Kong trading session on October 15, 2024), and announced that, according to Legend Biotech and Janssen Biotech, Inc. (Janssen) Under the cooperation and licensing agreement concluded on December 21, 2017, CARVYKTI® generated net trade sales of approximately US$286 million for the quarter ended September 30, 2024.